IP Library › Granted Patent US 10,583,204
Granted Patent B2
US 10,583,204 · App. 13/426,422 · Granted Mar 10, 2020

Methods for transfecting nucleic acid into live cells

Inventors: James Eberwine (Philadelphia, PA); Philip G. Haydon (Narberth, PA); Jai-Yoon Sul (Bensalem, PA); Hajime Takano (Lawrenceville, NJ); Chia-Wen Kitty Wu (Philadelphia, PA); Fanyi Zeng (Philadelphia, PA)
Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
A61K48/0083C12N13/00C12N15/1079C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,583,204
App. No.
13/426,422
Granted
Mar 10, 2020
Kind
B2
Abstract

The present invention includes methods for transferring a multigenic phenotype to a cell by transfecting, preferably by phototransfection, and locally transfecting a cell or a cellular process with a laser while the cell is bathed in a fluid medium comprising two or more nucleic acids, thereby introducing the nucleic acid into the interior of the cell. Expression of the nucleic acids results in a multigenic phenotype in the tranfected cell.

Claims (21)

1. A method of transferring a phenotype of a donor cell to a recipient cell, the method comprising:

transfecting a recipient cell with a transcriptome of a donor cell a first time, wherein the cell type of the donor cell is different than the cell type of the recipient cell, wherein the recipient cell is transfected in vitro or ex vivo, wherein the RNAs of the transcriptome enter the recipient cell, wherein the RNAs are functional in the recipient cell, and

transfecting the recipient cell with a transcriptome of the donor cell at least a second time, wherein the recipient cell is transfected in vitro or ex vivo, wherein the RNAs of the transcriptome enter the recipient cell, wherein the RNAs are functional in the recipient cell,

thereby initiating a change in physiology and morphology of the recipient cell, wherein the change in physiology and morphology yields a phenotype of the recipient cell that is indicative of the donor cell

wherein the donor cell and recipient cell are selected from the group consisting of:

a) wherein the recipient cell is a fibroblast, and wherein the donor cell is selected from the group consisting of an astrocyte, a cardiomyocyte, and a stem cell;

b) wherein the recipient cell is a neuron, and wherein the donor cell is selected from the group consisting of an astrocyte and a cardiomyocyte; and

c) wherein the recipient cell is an astrocyte and wherein the donor cell is a cardiomyocyte.

2. The method of claim 1 , wherein the method further comprises transfecting the recipient cell with at least one DNA of the donor cell.

3. The method of claim 1 , wherein the RNA is at least one selected from the group consisting of: mRNA, siRNA, miRNA, hnRNA, and tRNA.

4. The method of claim 1 , wherein the RNAs are expressed by the recipient cell.

5. The method of claim 1 , wherein the RNAs are isolated from a donor cell.

6. The method of claim 1 , wherein RNAs are in vitro transcribed.

7. The method of claim 1 , wherein the RNAs are prepared by a method selected from the group consisting of: mRNA isolation from a donor cell, in vitro mRNA transcription or mRNA chemical synthesis.

8. The method of claim 1 , wherein the phenotype of the recipient cell comprises two or more characteristics selected from the group consisting of: expression of the donor cell nucleic acid, protein expression of donor cell protein, expression of donor cell immunological markers, donor cell morphology, donor cell physiology, donor cell bioproduct synthesis, and donor cell membrane lipid composition.

9. The method of claim 1 , wherein the phenotype-of the recipient cell comprises three or more phenotype characteristics selected from the group consisting of: expression of the donor cell nucleic acid, protein expression of donor cell protein, expression of donor cell immunological markers, donor cell morphology, donor cell physiology, donor cell bioproduct synthesis, and donor cell membrane lipid composition.

10. The method of claim 1 , wherein the phenotype-of the recipient cell comprises four or more phenotype characteristics selected from the group consisting of: expression of the donor cell nucleic acid, protein expression of donor cell protein, expression of donor cell immunological markers, donor cell morphology, donor cell physiology, donor cell bioproduct synthesis, and donor cell membrane lipid composition.

11. The method of claim 1 , wherein the phenotype-of the recipient cell comprises the phenotype characteristics of donor cell morphology and donor cell physiology.

12. The method of claim 1 , wherein the recipient cell is a fibroblast, and wherein the donor cell is selected from the group consisting of an astrocyte, a cardiomyocyte, and a stem cell.

13. The method of claim 1 , wherein the recipient cell is a neuron, and wherein the donor cell is selected from the group consisting of an astrocyte and a cardiomyocyte.

14. The method of claim 1 , wherein the recipient cell is an astrocyte and wherein the donor cell is a cardiomyocyte.

Continuity (3)
Continuation 12086471
Provisional Application 60749941 · Dec 13, 2005
Related Publication 20120178167A1 · Jul 12, 2012
Cited By (1)
US 12,661,648